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Proinflammatory cytokines impact islet -cell mass and function by
altering the transcriptional activity within pancreatic -cells, produc-
ing increases in intracellular nitric oxide abundance and the synthesis
and secretion of immunomodulatory proteins such as chemokines.
Herein, we report that IL-1, a major mediator of inflammatory
responses associated with diabetes development, coordinately and
reciprocally regulates chemokine and insulin secretion. We discov-
ered that NF-B controls the increase in chemokine transcription and
secretion as well as the decrease in both insulin secretion and prolif-
eration in response to IL-1. Nitric oxide production, which is
markedly elevated in pancreatic -cells exposed to IL-1, is a nega-
tive regulator of both glucose-stimulated insulin secretion and glu-
cose-induced increases in intracellular calcium levels. By contrast, the
IL-1-mediated production of the chemokines CCL2 and CCL20 was
not influenced by either nitric oxide levels or glucose concentration.
Instead, the synthesis and secretion of CCL2 and CCL20 in response
to IL-1 were dependent on NF-B transcriptional activity. We
conclude that IL-1-induced transcriptional reprogramming via
NF-B reciprocally regulates chemokine and insulin secretion while
also negatively regulating -cell proliferation. These findings are
consistent with NF-B as a major regulatory node controlling inflam-
mation-associated alterations in islet -cell function and mass.
chemokine; inflammation; insulin secretion; interleukin-1; nitric oxide
THE PROGRESSION TO BOTH TYPE 1 (T1DM) and type 2 diabetes
mellitus (T2DM) proceeds via immune cell-associated altera-
tions in islet -cell mass and function. Alterations in islet
-cell mass and function are two major determinants control-
ling the total amount of insulin produced and secreted in
response to physiological stimuli (e.g., glucose). Proinflamma-
tory cytokines such as IL-1 and IFN contribute significantly
to losses in islet -cell viability and insulin secretion. Islet
-cells exposed to IL-1 and IFN undergo extensive genetic
reprogramming, which includes transcriptional increases in the
inducible nitric oxide synthase (iNOS) gene (13, 26) and
various genes encoding chemokines (8–10, 12, 44).
IL-1 induces the expression of the iNOS gene, promoting
marked accumulation of iNOS protein, a phenotype potentiated
by the addition of IFN (13, 16, 17, 26). The active iNOS
enzyme produces nitric oxide, a free radical signaling molecule
that impacts numerous cellular functions (5, 28, 46). In pan-
creatic -cells, nitric oxide influences insulin secretion, DNA
damage and repair, and overall cellular viability. In addition to
controlling the abundance of iNOS, IL-1 also promotes in-
creased production of a variety of chemokines (8, 44), which
are soluble secreted factors that regulate immune cell recruit-
ment and activation (25).
For example, CCL2 (a.k.a. MCP-1) is elevated in islets
isolated from diabetic mice (8) and from human islets exposed
to cytokines (21, 44). Transgenic mice with CCL2 production
driven within pancreatic -cells display enhanced recruitment
of immune cells into the pancreatic islets, although disease
outcome differs depending on genetic background (35, 36).
The chemokine CCL20 (a.k.a. LARC/MIP-3) is also elevated
within islets from mouse, rat, and humans during inflammation
(11, 14, 44). CCL20 and CCL2 recruit distinct populations of
leukocytes via the use of specific receptors. CCL2 signals
through CCR2 (present on monocytes and macrophages),
whereas CCL20 is a ligand for the CCR6 receptor (42).
Interestingly, CCL2, CCL20, and iNOS are all bona fide
target genes controlled by the NF-B family of transcription
factors (8, 11, 13). NF-B subunits include p65 (RelA), RelB,
c-Rel, p50 (NF-B1), and p52 (NF-B2). The NF-B pathway
is one of the major intracellular systems regulating inflamma-
tory responses (2). Therefore, understanding the mechanisms
underlying the IL-1-mediated, NF-B-regulated production
of chemokines and other signaling molecules, such as nitric
oxide, within pancreatic -cells is essential for developing
novel therapeutic strategies to prevent or reverse -cell death
and dysfunction. However, the precise mechanisms underlying
the phenotypic changes in pancreatic -cells in response to
IL-1 and nitric oxide are not completely understood.
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Toward this end, we have undertaken a systematic analysis
of the timing of insulin secretion, nitric oxide accumulation,
and chemokine production and release from pancreatic -cells.
We report herein that chemokine secretion increases, whereas
insulin secretion decreases, in response to IL-1. The NF-B
pathway is the central mediator of these outcomes. We further
found that elevations in nitric oxide negatively regulate insulin
secretion but have no effect on chemokine release. Moreover,
the secretion of chemokines is not influenced by changes in
glucose concentration but rather is controlled directly by
NF-B activity. We conclude that NF-B is the central regu-
lator of the reciprocal and coordinated changes in insulin and
chemokine secretion in pancreatic -cells during receipt of
proinflammatory signals.
MATERIALS AND METHODS
Cell culture, islet isolation, adenoviral vectors, and reagents.
Culture of 832/13 and 833/15 rat insulinoma cells and isolation of
islets from Wistar and Zucker diabetic fatty (ZDF) rats were carried
out as described previously (17, 18). All islet isolation protocols were
approved by the Duke University and the University of Tennessee
institutional animal care and use committees. All cell lines were
confirmed to be free of mycoplasma contamination. The generation
and use of adenoviruses encoding -galactosidase (27) and IBSR
(32) have been reported. IL-1 was purchased from Thermo Fisher
Scientific (Waltham, MA), IFN was purchased from Shenandoah
Biotechnology (Warwick, PA), NG-monomethyl-L-arginine (L-
NMMA) was from Cayman Chemical (Ann Arbor, MI), and dimethyl
malate was from Sigma Aldrich (St. Louis, MO). The spin trap
N-methyl-D-glucamine dithiocarbamate (MGD) was from ENZO Life
Sciences (Farmingdale, NY).
Total RNA isolation, cDNA synthesis, and RT-PCR. RNA isolation
from cell lines and rat islets, cDNA synthesis, and analysis of
real-time RT-PCR data has been described in detail previously (12).
For all transcripts studied, the relative mRNA abundance was nor-
malized to that of the housekeeping gene ribosomal S9. Primers used
to detect transcript levels of ribosomal S9, iNOS, IL-1, and Nkx6.1
were designed using Primer3Plus software and are available upon
request.
Cellular fractionation and immunoblot analysis. Cell lysis and
extraction of cytoplasmic and nuclear protein fractions was performed
using the NE-PER kit (Thermo Fisher Scientific) according to the
manufacturer’s directions. The protein concentration of the lysate was
determined using the bicinchoninic acid assay (Thermo Fisher Scien-
tific), using BSA as the standard. SDS-PAGE, transfer to polyvi-
nylidene difluoride membranes, membrane blocking before antibody
incubation, and downstream subsequent detection using a ChemiDoc
imaging system (Bio-Rad) have been described previously (16).
Antibodies detecting -actin or tubulin were used as loading controls.
Antibodies used were from the following sources: iNOS (Santa Cruz
Biotechnology), -actin (Cell Signaling Technology), IB (Santa
Cruz Biotechnology), tubulin (Cell Signaling Technology), and Pdx-1
(Cell Signaling Technology). The antibody recognizing Nkx6.1 has
been described (34). Immunoblot images were quantified using Image
Lab software (Bio-Rad).
ELISA. 832/13 cells were grown in 12-well plates and treated as
indicated. RPMI was supplemented with 0.3% BSA, and media were
collected at the indicated time points. In addition, the cells were lysed
using M-PER lysis reagent (Thermo Fisher Scientific) to quantify total
intracellular protein content. CCL2 and CCL20 secretion into the
media was measured by CCL2 Quantikine ELISA kit (R & D
Systems, Minneapolis, MN) and CCL20 DuoSet ELISA kit (R & D
Systems) according to the manufacturer’s protocol. ELISA data were
normalized to total protein to account for any differences in cell
number between treatment groups.
Nitrite and MTS assay. Nitrite in the cell culture media was
measured as an index of NO production using the Griess assay kit
(Promega, Madison, WI), whereas cellular reduction of the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium, inner salt (MTS) dye was determined using
the MTS 1 solution kit (Promega) according to the manufacturer’s
protocol.
Electron paramagnetic resonance spectroscopy. The spin trap
N-methyl-D-glucamine dithiocarbamate-iron complex [(MGD)2-Fe2]
was prepared fresh in each experiment by making stock solutions of 500
mM MGD and 100 mM Fe2 (from FeSO4.7 H2O) in ultrapure water
under anaerobic conditions. A final concentration of 25 mM MGD
and 5 mM Fe2 was introduced onto cells in culture using
serum-free media with a 30-min incubation period. Supernatants
were then collected for the measurements of the (MGD)2-iron-NO
complex. All electron paramagnetic resonance (EPR) measure-
ments were carried out in a quartz flat cell at room temperature.
Samples were transferred directly into the flat cell, which was then
placed into the cavity of a Bruker EMX Plus spectroscope. Typical
instrumental conditions were as follows: 20 mW of microwave
power, 5.0-G modulation amplitude, 1  105 gain, 0.163-s time
constant, and 80-G scan range. Quantitation was carried out by
measuring and comparing the first peak heights on the spectra.
Insulin secretion and tritiated thymidine incorporation assays.
832/13 cells were grown in 12-well plates and treated as indicated.
Glucose-stimulated insulin secretion (GSIS) assays were performed as
described previously (29). Insulin secretion by cell lines into the
media was measured using either the High Range Rat Insulin ELISA
kit (Mercodia, Uppsala, Sweden) or by rat islets using the insulin
radioimmunoassay (Siemens, Malvern, PA) according to the company
directions. In addition, cells were lysed using M-PER lysis reagent
(Thermo Fisher Scientific) to quantify total intracellular protein con-
tent via BCA assay (Thermo Fisher Scientific). Insulin secretion data
were normalized to total protein to account for any differences in cell
number between treatment groups. Incorporation of tritiated thymi-
dine into DNA as a cellular index of proliferation was carried out as
described (45).
Live cell calcium imaging. 832/13 cells were plated into six-well
plates containing poly-D-lysine-coated coverslips (Neuvitro, Vancou-
ver, WA). At 50% confluence, cells were treated for 18 h with one of
four experimental groups: 1 ng/ml IL-1 alone, 1 mM L-NMMA
alone, IL-1  L-NMMA, or normal growth media. Immediately
prior to imaging, cells were preloaded with Calcium Green 1 AM
(CG, C3012; Life Technologies) by transferring coverslips to a
solution of 10 M CG in 20% Pluronic F127 in DMSO (Life
Technologies) made up in carbogenated (95% O2-5%CO2) normal
Krebs. The recipe for normal Krebs solution was (in mM) 124 NaCl,
25 NaHCO3, 2 glucose, 3 KCl, 2 CaCl2, 1.5 NaH2PO4, and 1
MgSO4-7H2O, which corrected to pH 7.4 with HCl. After incubation
in the CG solution for 30 min, coverslips were transferred to carbo-
genated normal Krebs at 29°C.
Coverslips were transferred to a recording chamber on a fixed stage
Zeiss Axioskop2 microscope equipped with a Perkin Elmer Ultra-
view/Yokogawa C10 spinning disk laser confocal illuminator. Cells
were illuminated with the 488 nm laser; CG-calcium fluorescence
signals were collected at 509 nm. Cells were visualized with a 40
water immersion objective. Images were collected with a Ham-
mamatsu Ocra-ER charge-coupled device camera. The confocal sys-
tem, including image collection, was controlled by Perkin-Elmer
Improvision software.
Cells on coverslips were constantly perfused with normal Krebs
solution at 29°C at a rate of 3 ml/min. After 	10 min, the perfusion
solution was switched to one containing 12 mM glucose and propor-
tionally less sodium chloride to maintain osmolality. The 12 mM
glucose challenge was applied for 5 min, followed by a 5 min washout
period. Images of CG-labeled cells were collected continuously dur-
ing the challenge period at a rate of 20/min, with each frame taking
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1 s. Images were collected as TIFF stacks and processed using Nikon
Elements AR software. Individual cells in the field were designated as
regions of interest (ROI), and their fluorescence signal over time was
captured. Background fluorescence was subtracted from the fluores-
cence signal of individual ROIs. The relative changes in cytoplasmic
calcium in the cells were expressed as changes in fluorescence
[(
F/F)%], where F is the intensity of the baseline fluorescence signal
before stimulation and 
F is the difference between the peak fluo-
rescence intensity and the baseline signal. Therefore, magnitude of
response was normalized for each individual ROI.
Oxygen consumption assays. Oxygen consumption rates (OCR)
were measured using the XF24 Extracellular Flux Analyzer (Seahorse
Bioscience, Chicopee, MA). 832/13 cells were grown on cell culture
plates for 2 days prior to OCR assays being run. Cells were treated
with vehicle, 1 ng/ml IL-, 1 mM L-NMMA, or both IL-1 (1 ng/ml)
plus L-NMMA (1 mM) for 18 h prior to OCR being measured. The
oxygen consumption rate was measured over a 2-h period. Data
represent the calculated average area under the curve from six wells
per treatment group over multiple independent experiments.
Mitochondrial/nuclear DNA ratio analysis. Genomic DNA was
isolated using a DNeasy kit from Qiagen (Valencia, CA) per the
manufacturer’s protocol and quantified via quantitative PCR using
iTaq Universal SYBR Green Supermix (Bio-Rad). Mitochondrial
number was determined as the expression of genes encoded by
mitochondrial DNA (CO1 and ATP6) relative to nuclear genes
(NDUFA and SDHA) using the

CT method. This methodology has
been described previously (24). Primer sequences are available upon
request.
Fig. 1. IL-1 reciprocally regulates chemo-
kine and insulin secretion. A: 832/13 cells
were stimulated with 1 ng/ml IL-1 for the
indicated times. Secretion of insulin (solid
line) or CCL2 (dashed line) into the culture
media was quantified by ELISA. B: 832/13
cells were stimulated with 1 ng/ml IL-1 for
the indicated times. Relative mRNA abun-
dance of inducible nitric oxide synthase
(iNOS) was quantified by RT-PCR, with
protein abundance determined by immuno-
blotting (inset). C: 832/13 were treated with
1 ng/ml IL-1 for the indicated times, and
nitrite accumulation in the culture media was
assessed using the Griess assay. D: 832/13
and 833/15 insulinoma cells were either un-
treated (control) or stimulated with both 1
ng/ml IL-1 and 100 U/ml IFN for 18 h.
Insulin secretion was measured in response
to basal (2 mM) or stimulatory (16 mM)
glucose concentrations. E: isolated rat islets
were treated with AdCMV--galactosidase
(-Gal) or AdCMV-IB super-repressor
(IBSR) in the presence or absence of 1
ng/ml IL-1 and 100 U/ml IFN. Insulin
secretion during static incubation was mea-
sured and represented as percent of the stim-
ulated control. ***P  0.001 vs. untreated
(NT; black bars). Data are presented as
means  SE of 3 independent experiments.
**P  0.01; *P  0.05. NS, not significant.
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Electrophysiology. Cell culture dishes were mounted on the stage of
an Olympus IX70 inverted microscope. A reference Ag/AgCl pellet
served to ground the bath. Patch electrodes were pulled from thick-walled
borosilicate glass with a filament (outer diameter: 1.5 mm; inner diame-
ter: 0.86 mm; Sutter Instruments, Novato, CA) using a Flaming-Brown
Micropipette Puller (Sutter Instruments). Electrode resistance values
ranged from 4 to 7 M. Ruptured patch, whole cell voltage clamp
recordings were made using an Axopatch 1D-patch clamp amplifier
(Molecular Devices, Sunnyvale, CA). Data were recorded using pClamp
10.0 software (Molecular Devices). Unless otherwise indicated, all re-
agents were purchased from Sigma-Aldrich (St. Louis, MO). External
solutions consisted of the following (in mM): 116.7 NaCl, 20.0 TEACl,
3.0 CaCl2, 0.4 MgCl2, 4.0 glucose, and 10.0 HEPES. Voltage clamp
experiments were performed in the ruptured patch configuration using the
following internal solution (in mM): 100.00 CsAc, 10.0 CsCl, 2.0 MgCl2,
0.1 CaCl2, and 10.0 HEPES. Also included was an ATP regeneration
system to preserve Ca2 currents [3.0 ATP (dipotassium), 1.0 ATP
(disodium), 20.0 phosphocreatine, 2.0 GTP, and 50 U/ml creatine phos-
phokinase]. Cesium was used as a substitute for K to minimize currents
through voltage-gated K channels. Tetrodotoxin (300 nM; Alomone
Laboratories, Jerusalem, Israel) was included in the external solution to
block voltage-gated Na currents. The liquid junction potential error for
these solutions was estimated to be 13 mV (pClamp). Solutions were
adjusted to pH 7.4 with NaOH for external solutions and with CsOH for
internal solutions. A pressurized gravity flow perfusion system (1.5–2
ml/min) was used to deliver the external solutions (AutoMate Scientific,
Berkeley, CA).
Statistical analysis. All statistical analyses were performed using
GraphPad (La Jolla, CA) Prism 6.0 using one-way ANOVA, followed
by Tukey’s post hoc correction. For the live cell calcium imaging,
mean magnitude of responses for each experimental condition were
determined and analyzed using one-way ANOVA with Dunnett’s
multiple comparison pos-test analysis. Significance values are given
in the figure legends.
Fig. 2. NF-B is required for cytokine-mediated decreases in insulin secretion and cellular production of nitric oxide. A–F: 832/13 cells were transduced with
adenoviruses expressing either AdCMV--Gal [control (C)] or increasing doses of AdCMV-IBSR (low and high). Eight hours after adenoviral transduction,
cells were then NT or stimulated for an additional 18 h with 1 ng/ml IL-1. A: immunoblot analysis of whole cell lysates probed with antibodies against iNOS,
IB, and tubulin. Solid arrow, adenovirally overexpressed IB; dashed arrow, endogenous IB. B and C: densitometric analysis of iNOS (B) and IB (C)
protein abundance from the immunoblot shown in A. D: nitric oxide determination by electron paramagnetic resonance (EPR) spectroscopy combined with
N-methyl-D-glucamine dithiocarbamate (MGD)2Fe2 spin trap. E: quantification of the EPR spectroscopy data shown in D. F: nitrite accumulation in the media
was measured by Griess assay. G and H: 832/13 cells were cultured with the indicated adenoviruses for 8 h, followed by exposure to 1 ng/ml IL-1 for either
6 (G) or 18 h (H). Insulin secretion was measured in response to basal (2 mM) and stimulatory (16 mM) glucose concentrations, with data shown as %stimulated
control. The high dose of AdCMV-IBSR was used in H. *P  0.05 vs. -Gal-IL-1; **P  0.01 vs. -Gal-IL-1; #P  0.1 vs. -Gal-IL-1. Data represent
means  SE of 3 independent experiments.
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RESULTS
IL-1 reciprocally regulates chemokine and insulin se-
cretion. For decades, IL-1 has been associated with inhibition
of GSIS (43). Indeed, we observed a steady decrease in GSIS
over a time course of exposure to 1 ng/ml IL-1, with a 40 and
59% decrease in GSIS by 6 and 12 h, respectively (Fig. 1A). In
contrast to GSIS, the expression and secretion of the chemo-
kine CCL2 are markedly elevated in response to IL-1 (Fig. 1A
and data not shown). These data demonstrate clearly the
reciprocal regulation of chemokine and insulin secretion by
IL-1 (Fig. 1A).
Because elevations in nitric oxide have been linked with
decreases in GSIS (19, 20), we investigated the timing of iNOS
mRNA accumulation in response to IL-1. iNOS expression is
undetectable at both the transcript and protein level in the
absence of IL-1 but is rapidly induced upon cellular exposure
to IL-1 (Fig. 1B). The marked elevation in transcript abun-
dance (Fig. 1B) is congruent with the increase in iNOS protein
(Fig. 1B, inset) and nitrite accumulation (Fig. 1C), an index of
nitric oxide production. Thus, the accumulation of nitrite cor-
relates with the decrease in GSIS (compare Fig. 1, A and C).
We conclude that IL-1 reciprocally regulates insulin and
chemokine secretion in pancreatic -cells.
NF-B is required for cytokine-mediated decreases in insu-
lin secretion and cellular production of nitric oxide. The
NF-B pathway is strongly activated by IL-1 in pancreatic
-cells (6, 16), and the proinflammatory cytokines IL-1 and
IFN impair -cell function and viability through activation of
specific signaling pathways such as NF-B and STAT1 (16,
17, 26). The clonal -cell line 833/15 is resistant to losses in
Fig. 3. NF-B is required for IL-1-medi-
ated decreases in cellular proliferation. A and
B: islets were isolated from 8-wk-old lean
(fa/) and obese (fa/fa) Zucker diabetic
fatty (ZDF) rats (n  8 rats/group). RT-PCR
measurement of IL-1 (A) and Nkx6.1 (B) is
shown. C: 832/13 cells were transduced with
AdCMV--Gal or the high dose of AdCMV-
IBSR. Following an overnight incubation
with the indicated adenoviruses, cells were
either left untreated or exposed to 1 ng/ml
IL-1 for 4 h. Cytosolic and nuclear frac-
tions were immunoblotted using antibodies
directed against iNOS, Nkx6.1, Pdx-1, and
tubulin. D: densitometric analysis of Nkx6.1
protein abundance normalized to the abun-
dance of tubulin. E: 832/13 cells were trans-
duced with AdCMV--Gal or the high dose
of AdCMV-IBSR for 8 h, followed by 18
h of exposure to 1 ng/ml IL-1. Tritiated
thymidine incorporation into DNA was mea-
sured at the end of the 18-h cytokine exposure.
Data represent means  SE of a minimum of
3 independent experiments, whereas the im-
munoblot represents 2 independent experi-
ments. **P  0.01 vs. lean (fa/) control;
***P  0.001 vs. -Gal-NT.
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viability upon exposure to IL-1 and IFN (17, 47). Using
clonal -cell lines, which are either sensitive (832/13) or
resistant (833/15) to killing by IL-1  IFN, we tested
whether or not insulin secretion was preserved in the cytokine-
resistant 833/15 cells. Under normal conditions (i.e., no cyto-
kines present), GSIS was similar between 832/13 and 833/15
cells (Fig. 1D, black bars). However, when cultured overnight
in the presence of IL-1 and IFN, only 833/15 cells retained
the ability to secrete insulin in response to a glucose stimulus
(Fig. 1D, open bars).
An inherent defect in NF-B-mediated gene activation in the
833/15 cell line was reported (15), which we interpreted as the
reason for their protection against cytokine-mediated im-
pairments in GSIS. To directly test this possibility, we used
adenoviral delivery of a mutated form of IB that contains
S32A/S36A substitutions, termed the IB super-repressor
(IBSR). The IBSR retains the p65 subunit of NF-B in
the cytosol and thus decreases NF-B transcriptional activ-
ity (11, 16). Culturing rat islets in IL-1 and IFN overnight
completely suppressed GSIS; this loss in function was
reversed in islets transduced with the IBSR, but not in
islets receiving a control virus expressing -galactosidase
(Fig. 1E).
To investigate the contribution of NF-B to nitric oxide
production after cellular exposure to IL-1, we first analyzed
iNOS protein abundance in the presence and absence of the
IBSR. Again, iNOS protein is undetectable in the absence of
a cytokine stimulus but accumulates upon cellular exposure to
IL-1 (Fig. 2A). Inhibiting NF-B transcriptional activity,
using adenoviral transduction of 832/13 cells with IBSR,
decreases iNOS protein abundance by 73% at the highest viral
dose (Fig. 2A; quantified in Fig. 2, B and C).
Fig. 4. IL-1 generates elevations in nitric
oxide production and decreases in oxygen
consumption. A–D: 832/13 cells were co-
treated with 1 ng/ml IL-1 and 1 mM
NG-monomethyl-L-arginine (L-NMMA) for
18 h. A: nitrite was measured in the culture
media using the Griess method. B and C:
nitric oxide was measured by EPR spectros-
copy combined with (MGD)2Fe2 spin trap-
ping. D: insulin secretion was measured in
response to basal (2 mM) or stimulatory (16
mM) glucose concentrations. E: 832/13 cells
were NT or exposed to 1 ng/ml IL-1 for 18
h. Glucose-stimulated insulin secretion was
measured in response to basal (2 mM) or
stimulatory (16 mM) glucose concentrations
in the presence or absence of 10 M dim-
ethylmalate (DMM), with DMM added only
during the final 2 h of the secretion experi-
ment. Data are presented as means  SE of
3 independent experiments. ***P  0.001;
**P  0.01; *P  0.05.
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Using EPR spectroscopy in conjunction with the spin trap
(MGD)2Fe2, we observed robust production of nitric oxide in
response to IL-1 (spectra shown in Fig. 2D). This technique
specifically measures nitric oxide radicals. Reducing iNOS
expression with the IBSR diminished nitric oxide production
in a manner consistent with the decrease in iNOS protein (Fig.
2, A and D). Quantification of the signal intensity from multiple
EPR experiments is shown in Fig. 2E. The Griess assay, which
measures total nitrite accrual in the media from both organic
and inorganic sources, also revealed decreased nitrite produc-
tion when iNOS protein levels were reduced by blocking
NF-B activity (Fig. 2F). This diminution in nitric oxide levels
correlated directly with the complete recovery of IL-1-medi-
ated impairments in GSIS in 832/13 clonal -cells cultured for
6 (Fig. 2G) and 18 h (Fig. 2H) with IL-1. We interpreted
these data to indicate that transcriptional activation of the iNOS
gene by NF-B controls iNOS enzyme accumulation and
subsequent nitric oxide production, which serves as a negative
regulator of insulin secretion.
NF-B is required for IL-1-mediated decreases in cellular
proliferation. A reduction in islet -cell mass and function is a
hallmark of both T1DM and T2DM. The Zucker diabetic fatty
(ZDF) rat is a model of obesity and diabetes resulting from
reduced functional -cell mass (4). Using isolated islets from
8-wk-old ZDF rats, we found that IL-1 expression was
elevated 8.6-fold (Fig. 3A). Nkx6.1 expression was reduced by
52% in islets isolated from ZDF rats relative to their lean
littermate controls (Fig. 3B). Because the transcription factor
Fig. 5. Nitric oxide decreases oxygen con-
sumption rate without affecting mitochon-
drial number. A–D: 832/13 and 833/15 cells
were NT or treated with 1 ng/ml IL-1 alone
or IL-1  100 U/mL IFN for either 6 or
18 h. Mitochondrial number was determined
using the ratio of mitochondrial DNA (CO1
or ATP6) relative to nuclear DNA (NDUFA
or SDHA). E and F: 832/13 cells were ex-
posed to 1 ng/ml IL-1 in the presence or
absence of 1 mM L-NMMA for 18 h. Cellu-
lar ability to reduce the MTS [3-(4,5-dim-
ethylthiazol-2-yl)-5-(3-carboxymethoxyphe-
nyl)-2-(4-sulfophenyl)-2H-tetrazolium, in-
ner salt] dye (E) and area under the curve
(AUC) analysis of oxygen consumption rate
(OCR; F) are shown. Values represent
means  SE of 3 independent experiments.
**P  0.01; *P  0.05.
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Nkx6.1 regulates -cell proliferation (45), we next examined its
abundance under conditions of IL-1 exposure in the presence or
absence of the IBSR. 832/13 cells exposed to IL-1 for 4 h
displayed robust iNOS abundance, which was blocked by the
IBSR (Fig. 3C). Nkx6.1 was largely nuclear, and its abundance
was decreased by 47% after IL-1 exposure (Fig. 3, C and D).
Moreover, the ability to incorporate thymidine into DNA, an
index of proliferation, was reduced markedly in 832/13 -cells
exposed to IL-1 for 18 h but was restored in cells expressing
the IBSR (Fig. 3D). Thus, blocking NF-B activity with the
IBSR restored Nkx6.1 abundance (Fig. 3C), which was
consistent with the recovery in cellular thymidine incorpora-
tion (Fig. 3E). The amount of Pdx-1 protein was unchanged
under these conditions. These observations are consistent with
IL-1-mediated decreases in proliferation being controlled by
NF-B activation.
IL-1 generates elevations in nitric oxide production and
decreases in oxygen consumption. IL-1 promotes robust ac-
cumulation of the iNOS protein (Fig. 1 and Ref. 26) and nitrite
accumulation, which impairs insulin secretion; this effect can
be prevented by blocking NF-B transcriptional activity (Figs.
1 and 2). Therefore, we used L-NMMA, an arginine analog that
inhibits all known nitric oxide synthase isoforms (39), and
found that the increase in total nitrite production by cellular
Fig. 6. Nitric oxide mediates the IL-1-mediated
impairment in glucose-stimulated calcium re-
sponses. A: 832/13 cells were cotreated for 18 h with
1 ng/ml IL-1 and 1 mM L-NMMA, followed by a
bath-applied glucose challenge to evoke elevations
in intracellular calcium levels as measured by
changes in fluorescence. *P  0.05. B: whole cell
voltage clamp recordings from a control and an
IL-1-treated cell. Cells were held at 70 mV and
then stepped for 300 ms to a series of voltages
ranging from 103 mV to 17 mV. Shown are the
currents generated by the step to 3 mV. Voltage
step values are corrected for the liquid junction
potential (13 mV). C: mean current densities
(voltage step to 3 mV) were plotted for control
and IL-1-treated cells. No significant difference in
current amplitude was observed (n  25 for both).
D: capacitance values for the 2 groups of cells
indicate that cell size for IL-1-treated cells was
also not significantly different from control (n  25
for both).
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exposure to IL-1 was completely inhibited (Fig. 4A). The
EPR (MGD)2 Fe2 spin trap methodology also revealed a lack
of IL-1-mediated elevations in nitric oxide formation when
L-NMMA was present (Fig. 4B; representative spectra shown
in Fig. 4C). Therefore, we next addressed whether L-NMMA
prevented the suppression of insulin secretion upon exposure to
IL-1. We observed an almost complete recovery of insulin
secretion in the presence of IL-1  L-NMMA (Fig. 4D). In
addition, insulin secretion could be recovered by dimethyl
malate (Fig. 4E), a malate analog, indicating that mitochondrial
metabolism was still active in the presence of IL-1.
To address whether mitochondrial number or mitochondrial
function is altered by IL-1, we first measured the mitochon-
drial/nuclear DNA ratios, which have been used to track
changes in mitochondrial biogenesis (24). We did not detect
any alterations in mitochondrial/nuclear DNA ratios (Fig. 5,
A–D), which we interpreted as evidence that mitochondrial
number was not being altered in response to either IL-1 or the
combination of IL-1  IFN.
Therefore, we next investigated whether mitochondrial func-
tion was reduced. We found a 38% decrease in reduction of the
MTS dye after IL-1 exposure (Fig. 5E). This decrease was
fully recovered in the presence of the NOS inhibitor L-NMMA
(Fig. 5E). In addition, a 25% decrease in cellular oxygen
consumption rate was identified, which was also prevented by
the addition of 1 mM L-NMMA (Fig. 5F). We conclude that
enhanced cellular abundance of nitric oxide diminished mito-
chondrial activity but did not alter total mitochondrial number.
Nitric oxide mediates the IL-1-induced impairment in glu-
cose-stimulated calcium elevations. Nitric oxide suppresses
insulin secretion in mouse, rat, and human islets (5). Using
832/13 rat clonal -cells, which display similar impairments in
Fig. 7. NF-B, but not glucose or nitric
oxide concentration, controls production of
the chemokines CCL2 and CCL20 in re-
sponse to IL-1. A and B: 832/13 cells were
cotreated for 6 h with 1 ng/ml IL-1 and 1
mM L-NMMA. C and D: 832/13 cells were
transduced with adenoviruses overexpress-
ing either AdCMV--Gal or increasing
doses of AdCMV-IBSR (low and high).
Twelve hours after adenoviral transduction,
cells were then NT or exposed to 1 ng/ml
IL-1 for an additional 6 h. E and F: 832/13
cells were NT or exposed to 1 ng/ml IL-1
for 6 h in the presence of increasing concen-
trations of glucose (2, 4, 8, or 16 mM).
Release of CCL2 (A, C, and E) and CCL20
(B, D, and F) into the culture media was
measured by ELISA assays. Data represent
means  SE of a minimum of 3 independent
experiments. ***P  0.001 vs. -Gal-IL-
1; **P  0.01 vs. -Gal-IL-1.
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insulin secretion, as observed in isolated islets, we examined
changes in cytoplasmic calcium using the reporter dye calcium
green in conjunction with confocal microscopy. In control
pretreated cells, 	97% of the cells responded to the glucose
challenge with an averaged response magnitude of 33% change
in fluorescence levels. In cells pretreated with IL-1 alone,
only 61% of the cells responded to the glucose challenge at an
average response magnitude of 20%. However, the pretreat-
ment of cells with L-NMMA plus IL-1 rescued both the
number of responsive cells (89%) and the magnitude of the
response (30%) of these cells to the glucose challenge. Cells
pretreated with L-NMMA alone differed neither in the number
of responders nor in the magnitude of the responses to the
glucose challenge relative to control pretreatment. Thus, the
responses of cells pretreated with IL-1 alone were reduced by
39% relative to the responses of the control group (Fig. 6A).
This reduced change in intracellular calcium observed with
IL-1 was completely prevented by 1 mM L-NMMA (Fig. 6A),
indicating a requirement for nitric oxide production to alter the
glucose-induced increase in cytoplasmic calcium levels.
To test for a decrease in the activity of voltage-gated Ca2
channels, whole cell voltage clamp recordings were made from
individual 832/13 clonal -cells (Fig. 6B). Voltage-gated Ca2
current density was not significantly different in control or
IL-1-treated cells (Fig. 6C), and IL-1 pretreatment also had
no effect on cell size as indicated by whole cell capacitance
measurements (Fig. 6D). We conclude that nitric oxide accu-
mulation most likely decreases calcium release from internal
stores and not by reducing the activity of voltage-gated calcium
channels.
NF-B, but not glucose or nitric oxide concentration, con-
trols production of the chemokines CCL2 and CCL20. Because
nitric oxide is a signaling molecule whose elevated abundance
reduces insulin secretion, we next investigated whether chemo-
kine secretion, a process also driven by IL-1, was altered by
changes in either glucose or nitric oxide concentration. IL-1
strongly induced the synthesis and secretion of CCL2 in
pancreatic -cells, which are not altered by the addition of 1
mM L-NMMA (Fig. 7A). Similarly, CCL20 secretion is not
impacted by suppressing nitric oxide production using
L-NMMA (Fig. 7B). By contrast, inhibiting NF-B transcrip-
tional activity via adenoviral delivery of the IBSR dose
dependently decreases the expression of the CCL2 gene (Ref.
10 and data not shown) and release of CCL2 protein (Fig. 7C).
Similar results were observed for CCL20 release (Fig. 7D).
Finally, we also investigated whether chemokine secretion was
dependent on the glucose concentration. Although glucose
concentration is the major determinant controlling insulin se-
cretion (37), the IL-1-induced secretion of both CCL2 and
CCL20 is not different over a range of glucose concentrations
(Fig. 7, E and F).
DISCUSSION
A diminution in the function and mass of pancreatic islet
-cells is a hallmark of both major forms of diabetes (1, 7).
Although extended exposure of islet -cells to proinflamma-
tory cytokines decreases viability, less is known about the early
changes that occur in response to the initial transcriptional
reprogramming events. Therefore, we undertook the present
study to investigate the acute functional responses of -cells to
the proinflammatory cytokine IL-1. Several novel observa-
tions emerged. 1) Chemokine secretion occured rapidly (within
3–6 h) after cellular exposure to IL-1; 2) insulin secretion
began to decrease by 6 h, concomitant with elevations in nitric
oxide production and reduction in the abundance of Nkx6.1. 3)
the decline in proliferation after exposure to IL-1 was con-
sistent with decreases in Nkx6.1 abundance; 4) all of these
processes were reversed by blocking NF-B transcriptional
activity; and 5) chemokine release was not dependent on
glucose concentration or nitric oxide accumulation, whereas
elevations in cellular nitric oxide levels negatively regulated
insulin secretion.
The 5.5-fold increase in nitrite accrual (Fig. 1B) at 6 h is
connected with a 36% decrease in GSIS, whereas a 13-fold
increase in nitrite is associated with a 54% diminution in GSIS
(Fig. 1). Because measurements of total nitrite production by
the Griess method account for both organic and inorganic
nitrite-containing compounds, we used the MGD spin trap
coupled with EPR spectroscopy to unequivocally measure
nitric oxide production. Accrual of nitric oxide was inversely
correlated with insulin secretion, implicating this free radical
signaling molecule as a negative regulator of insulin release in
-cells. However, the mitochondria are still functional in
-cells exposed to IL-1, as evidenced by enhanced insulin
secretion in the presence of dimethyl malate (DMM; a malate
analog). Because mitochondrial substrate metabolism is tightly
linked with insulin secretion (37), the ability of DMM to rescue
insulin secretion is consistent with nitric oxide functioning as
Fig. 8. NF-B coordinately regulates chemokine and insulin secretion, with
concomitant alterations in proliferation during exposure to IL-1. IL-1
signals through the IL-1 receptor I (IL-1RI), which promotes the phosphory-
lation-induced degradation of the IB regulatory protein. Degradation of
IB allows the p65 subunit of NF-B to move into the nucleus. NF-B
controls the expression of multiple target genes, including iNOS and numerous
chemokines. The coordinated changes in gene transcription include increased
expression of the iNOS gene, which leads to enhanced production of nitric
oxide (NO·). NO· serves as a negative regulator of glucose-stimulated insulin
secretion (GSIS). Intracellular calcium is stored in both endoplasmic reticulum
(ER) and mitochondria, and the signal-specific release of calcium (e.g., in
response to glucose) is potentially inhibited by elevations in intracellular nitric
oxide, contributing to diminished insulin secretion. The decrease in cellular
OCR is also consistent with the depletion of ATP observed in -cells exposed
to cytokines (17). In addition, IL-1 decreases proliferation in an NF-B-
dependent manner, with concomitant upregulation of chemokine synthesis and
secretion. Increasing the amount of chemokines released from -cells influ-
ences both innate and adaptive immune responses. Unlike insulin secretion,
-cell chemokine secretion is independent of cellular nitric oxide levels.
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an intracellular signaling intermediary to decrease insulin se-
cretion after exposure to IL-1.
DMM also improves insulin secretion in islets isolated from
ZDF rats and clonal -cells cultured in lipids (4). We have
shown herein that ZDF islets display elevated levels of IL-1
mRNA relative to lean control islets (Fig. 3). This finding is
consistent with IL-1 serving as a common link to alterations
in islet function and mass in both T1DM and T2DM. Further-
more, if nitric oxide is removed from cells within the first 24 h
of IL-1 exposure, mitochondrial metabolism and insulin se-
cretion are restored (5). In this study, we found that voltage-
gated calcium channel activity is not different between control
and IL-1-exposed cells, but the ability to increase intracellu-
lar calcium in response to a glucose challenge is diminished
(Fig. 6). Thus, nitric oxide accumulation most likely prevents
the release of calcium from internal storage depots, which
is consistent with reduced insulin release observed in our
studies and complementary to findings from previous studies
(38). Collectively, we interpret these data to indicate that the
mitochondria are responsive to both nitric oxide and metabolic
signals and that an initial increase in intracellular nitric oxide
production acts as a rheostat to rapidly and reversibly diminish
insulin secretion in response to a specific inflammatory signal
(e.g., IL-1) via multiple mechanisms.
In contrast to insulin secretion, the synthesis and release of
chemokines in response to IL-1 is completely independent of
either the glucose concentration or nitric oxide accumulation.
We discovered that the major control point for both IL-1-
mediated reduction in insulin secretion and enhancements in
chemokine production is NF-B activation. Indeed, several
chemokines are primary response genes in pancreatic -cells
exposed to IL-1 (Refs. 8 and 12 and data not shown), which
may be explained at least in part by the exquisite sensitivity of
the pancreatic -cell to IL-1 receptor (IL-1R) activation. The
marked sensitivity of -cells to IL-1 is due largely to the high
level of IL-1R expression (3). Thus, at least one of the major
consequences of islet -cell signaling via IL-1R ligands (e.g.,
IL-1) is the rapid and reciprocal regulation of chemokine and
insulin secretion. Consequently, the islet -cell may play a
much more important role in regulating immune system func-
tion than has been recognized previously. Along these lines,
insulin has documented anti-inflammatory properties (30, 31).
Therefore, -cell insulin release may have a greater impact on
innate and adaptive immunity than realized previously, which
would fit with a need to coordinately downregulate insulin
secretion during periods of inflammation. Because chemokines
control both immune cell recruitment as well as immune cell
activity, changes in the islet -cell ratio of insulin to chemo-
kine secretion could have important consequences for both
local and systemic inflammatory responses as well as for
metabolic homeostasis.
The progression to both T1DM and T2DM requires immune
cell-associated alterations in islet -cell mass and function.
With many discrete chemokines made in response to IL-1 and
IFN in pancreatic -cells (8, 44), the -cell influence on
tissue leukocytosis and overall pancreatic inflammatory re-
sponses may be underappreciated. It also appears that NF-B is
the major regulatory factor controlling chemokine production
in response to IL-1 (9, 10, 12), whereas STAT1 is the
predominant transcription factor mediating the increased
chemokine production by IFN (9, 12). Furthermore, NF-B is
the key determinant of the chemokine/insulin secretion ratio,
suggesting that modulation of NF-B would be beneficial for
improving islet function by suppressing inflammatory re-
sponses. The results of a variety of in vitro and in vivo studies
support this rationale (21–23, 33, 40, 41), and a recent com-
putational model predicted elevated IL-1 signaling as neces-
sary and sufficient to promote progression to T2DM (48).
In summary, we have shown herein that IL-1 signaling via
NF-B controls both insulin and chemokine secretion and also
mediates decreases in -cell proliferation (Fig. 8). Thus, the
transcriptional reprogramming of -cells, such as that which
occurs after exposure to IL-1, is a major biochemical and
molecular process controlling both islet -cell insulin secretion
and pancreatic leukocyte infiltration via chemokine release.
Understanding the molecular mechanisms underlying these
signal-induced genetic events should provide novel insights
into therapeutic possibilities to prevent loss in -cell function
and mass.
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